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Feline infectious peritonitis (FIP) is a progressive, fatal, predominantly
Arthus-type immune-mediated disease that is triggered when cats are infected
with a mutant enteric coronavirus. The disease presents variably with multiple
organ failure, seizures, generalized effusion, or shock. Neurological FIP is
clinically and pathologically more homogeneous than systemic ‘wet’ or ‘dry’ FIP;
thus, comparison of cytokine profiles from cats with neurological FIP, wet FIP,
and non-FIP neurological disease may provide insight into some baseline
characteristics relating to the immunopathogenesis of neurological FIP. This
study characterizes inflammation and changes in cytokines in the brain tissue of
FIP-affected cats. Cellular infiltrates in cats with FIP included lymphocytes,
plasma cells, neutrophils, macrophages, and eosinophils. IL-1, IL-6, IL-12, IL-18,
TNF-, macrophage inhibitory protein (MIP)-1, and RANTES showed no
upregulation in the brains of control cats, moderate upregulation in neurological
FIP cats, and very high upregulation in generalized FIP cats. Transcription of
IFN- appeared upregulated in cats with systemic FIP and slightly
downregulated in neurological FIP. In most cytokines tested, variance was
extremely high in generalized FIP and much less in neurological FIP. Principal
components analysis was performed in order to find the least number of
‘components’ that would summarize the cytokine profiles in cats with
neurological FIP. A large component of the variance (91.7%) was accounted for
by levels of IL-6, MIP-1, and RANTES. These findings provide new insight into
the immunopathogenesis of FIP and suggest targets for immune therapy of this
disease.
© 2003 ESFM and AAFP. Published by Elsevier Ltd. All rights reserved.
Introduction
Feline infectious peritonitis (FIP) is a pro-gressive Arthus-type immune-mediateddisease, predominantly of cats from
multiple-cat households (Pedersen 1995b, Foley
et al 1997). The disease develops after a mutant
enteric coronavirus gains entry into the feline
macrophage and the cat’s innate immune system
fails to contain and eliminate the intracellular in-
fection. Infected macrophages disseminate sys-
temically and trigger immunological processes
resulting in microgranuloma formation, vascu-
litis, organ failure, and death (Pedersen and Boyle
1980, Poland et al 1996, Vennema et al 1998).
Many details of this process are poorly under-
stood, including the immunopathogenesis of the
disease. The tremendous clinical variability in FIP
has made investigating the immunopathology
difficult.
Neurological FIP, which is clinically and patho-
logically more homogeneous than systemic FIP,
is a good system for establishing baseline char-
acteristics of immunopathogenesis (Foley and
Leutenegger 2001). Neurological FIP occurs in
about 1/3 of the cats with FIP (Fenner 1991, Kline
et al 1994, Foley et al 1998), and presents with
weight loss, fever, ataxia, dementia, and other
abnormal neurological signs (Kornegay 1978,
August 1984, Kline et al 1994, Foley et al 1998).
Neurological FIP consists of meningitis, epen-
dymitis, periventriculitis, and choroiditis, some-
times leading to obstructive hydrocephalus
(Slauson and Finn 1972, Krum et al 1975,
Legendre and Whitenack 1975, Kornegay 1978,
Tamke et al 1988, Summers et al 1995, Foley et al
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1998). Often there is little coronavirus present in
FIP-affected brain tissue (Foley et al 1998), yet
inflammatory cells are recruited to the brain and
contribute to disease, in part, through secretion of
cytokines. Little is known about cytokine secre-
tion in FIP, although preliminary studies have
described increases in IL-10 (Dean et al 1997), IL-6
and IL-1 (Goitsuka et al 1990), and IL-1
(Hasegawa and Hasegawa 1991), and reductions
in IL-2, IL-4, IL-10, and IL-12 (Gunn-Moore et al
1998) in generalized FIP. No information is avail-
able regarding cytokine production in neurologi-
cal FIP and how cytokines compare, in this tissue,
with abdominal tissues of cats with generalized or
effusive FIP. The purpose of this study was to
compare cytokines in the brains of FIP-affected
cats with that in the brains of control cats (well




Formalin-fixed brain tissue was collected from
four groups of cats, all of which had been patients
at the UC Davis Veterinary Medical Teaching
Hospital (VMTH) and had been euthanized at the
request of owners (including the healthy con-
trols). Ten cats had histopathologically confirmed
neurological FIP and no extra-CNS disease
(referred to as neurological FIP). Seven cats had
neurological and concurrent extra-CNS FIP (gen-
eralized FIP). The cats with FIP represented all
confirmed cases of FIP seen at the VMTH over the
previous 5 years from which sufficient tissue
could be obtained. Eleven cats had non-FIP
neurological disease, and seven cats were healthy
controls with pathologically normal brains. As for
the cats with FIP, these cases were chosen on the
basis of availability and the fact that they met the
criteria for controls. Clinical abnormalities were
described according to a scale (Table 1).
Pathological evaluation
Full necropsies were performed on all cats by
pathologists in the VMTH Pathology Service
within 12 h of the death of each cat. Brain samples
were thinly sliced, placed overnight in 10% buff-
ered formalin, embedded in paraffin, and then
sectioned onto glass slides for staining with
hematoxylin and eosin. All histological slides
were reviewed by VMTH pathologists and one of
the investigators (JEF) before further processing.
The pathological summaries include all inflam-
matory cells visualized in all brain sections. All
the reviewed slides included sections of cer-
ebrum, cerebellum, and brainstem; in some cats,
additional sections were available and these were
included whenever available.
Diagnostic testing: serology and reverse
transcription-polymerase chain reaction
Serology was performed by indirect immuno-
fluorescence assay (IFA), using Felis catus whole
fetal-4 cells infected with FIPV-UCD1 as sub-
strate, as previously described (Pedersen 1995a).
Samples were tested starting at dilutions of 1:25 to
endpoint, and positive and negative control sera
included in each run. The titer was considered the
highest dilution at which characteristic bright
green fluorescence could be detected.
For reverse transcription-polymerase chain re-
action (RT-PCR), RNA was extracted from 50 µm
sections of formalin-fixed, paraffin-embedded
cerebrum, cerebellum, medulla, and midbrain fol-
lowing pretreatment with xylene in 70% ethanol.
All the available sections from each cat were
pooled for extraction, a minimum of two in one
cat and a maximum of four per cat, after prelimi-
nary statistical analysis to ensure that within-cat
Table 1. Clinical score for cats with neurological FIP
0=well cat, no evidence of FIP
1=early mild signs only, including anterior uveitis, keratic precipitates, palpable or ultrasound-visible hepatic or
renal granulomas, mesenteric lymphadenopathy
2=moderate progressive signs, including weight loss, fever, meningitis, abnormal CSF (elevated protein, cells, and/or
RT-PCR-positive), mild renal or hepatic insufficiency, mild neurological dysfunction
3=severe progressive signs, including severe neurological dysfunction±seizures or paralysis, characteristic ascitic or
pleural fluid, moderate to severe organ insufficiency, ±dyspnea
4=end-stage FIP, including recumbency, non-responsiveness, obtundation, seizures, hydrocephalus, hypothermia or
evidence of shock, renal or hepatic failure
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variance was low enough to justify this. The
sample was resuspended in lysis buffer (DNeasy
Tissue kit, Qiagen, Valencia, CA) and incubated
with proteinase K at 56°C for 14 h. Samples were
aliquotted into two (for extraction of RNA separ-
ately from DNA) and nucleic acids were extracted
using the kit. In one aliquot, genomic DNA was
digested with DNase I (Promega, Madison, WI) at
37°C for 40 min and the reaction was terminated
at 95°C for 5 min followed by chilling on ice. In
the other aliquot, genomic DNA was dissolved
in DEPC-treated water, quantitated by spectro-
photometry, and diluted to 20 ng/µl.
RT reactions were performed with 10 µl of
tRNA preincubated with 600 ng random hexa-
deoxyribonucleotide (pd(N)6) primers (random
hexamer; Promega). RT was performed in a 20 µl
volume containing 50 mM Tris–HCl (pH 8.3),
40 mM KCl, 6 mM MgCl2, 0.5 mM dNTPs, 40 U
RNase inhibitor (Gibco BRL, Life Technologies,
Grand Island, NY), 5 mM dithiothreitol (DTT),
and 200 U SuperScript II (Gibco BRL) at 42°C for
50 min. After 5 min at 95°C, 80 µl of DEPC water
was added.
Real-time TaqMan PCR systems for feline
GAPDH, FIPV, IL-4, IL-10, IL-12 p40, and inter-
feron (IFN)- were as previously described (Gut
et al 1999, Leutenegger et al 1999). Systems for
IL-1, IL-6, IL-18, IFN-, tumor necrosis factor
(TNF)-, macrophage inflammatory protein
(MIP)-1, and RANTES were designed using
Primer Express software (Applied Biosystems,
Foster City, CA). The internal probe was labeled
at the 5# end with the reporter dye FAM
(6-carboxy-fluorescein), at the 3# end with the
quencher dye TAMRA (6-carboxytetramethyl-
rhodamine), and was phosphate-blocked at the 3#
end to prevent extension. The sense and the anti-
sense primers were placed in two consecutive
exons of the gene; the probe spanned the junction
over the two exons between the sequences
covered by the two primers. For the intronless
genes, IFN- and RANTES, the systems did not
discriminate between cDNA and gDNA. The
primer and probe sequences for newly described
feline real-time TaqMan RT-PCR systems are
described in Table 2.
PCR reactions contained 400 nM of each
primer, 80 nM of the TaqMan probe and master-
mix (TaqMan Universal PCR Mastermix, Applied
Biosystems), and 5 µl of the diluted cDNA sample
in a final volume of 25 µl; samples were amplified
in a combined thermocycler/fluorometer (ABI
Prism 7700 Sequence Detection System, Applied
Biosystems) for 2 min at 50°C, 10 min at 95°C, and
then 40 cycles of 15 s at 95°C and 60 s at 60°C.
Final quantitation was done using the compara-
tive CT method (Leutenegger et al 1999) and is
reported as relative transcription or the n-fold
difference relative to a calibrator cDNA (ie the
lowest level of cytokine transcription in brain
tissue from a well-cat control).
Statistical analysis
Statistical analysis was performed using ‘R’ (R-
Development Core Team). A Wilcox signed rank
test was used to compare clinical scores and
Mann–Whitney U-test to compare FECV titers.
The t-tests were used to compare the means of
transcription of coronavirus RNA, serum protein,
and serum globulins in cats with neurological vs
generalized FIP. Cytokine levels among groups
were compared by single-factor ANOVA. Prior to
this analysis, within-cat variance was assessed to
ensure that it was appropriate to pool tissue for
cytokine analysis. Three to four duplicate sections
of the CNS of six cats, three with systemic FIP and
three with neurological FIP, were separately ex-
tracted and evaluated for cytokine mRNA by
PCR. Within-cat variance was compared with
between-cat variance to determine whether it was
valid to lump samples from within a cat. Results
of the ANOVA indicated statistical significance
for all cytokines except IL-4, IL-10, IL-12, IL-18,
and IFN-, indicating that levels of the other
cytokines from multiple sections from a single cat
were much more similar to each other than to
sections from other cats. The P-values were 0.02
for IL-1, 0.03 for IL-6, 0.01 for IFN-, 0.007 for
TNF-, 0.05 for MIP-1, and 0.002 for RANTES.
Further analysis consisted of principal compo-
nents analysis (PCA), in order to identify major
contributory cytokines in the profiles. This
method recharacterizes variables into several
principal components (PC) that maximally ac-
count for variance in the variables. The loadings
give the relative strengths and orientations of the
variables to the first several important PCs. In
other words, the first PC is an axis that goes
through the centroid (of the data cloud) in such a
way so as to minimize the average square dis-
tance of the points from the axis. The second PC
also goes through the centroid, through the maxi-
mum variation in the data, but must be com-
pletely uncorrelated with PC1. Results of
statistical tests were considered significant if the
probability of obtaining the observed results by
chance alone was%0.05.
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Table 2. Sequences of PCR primers and TaqMan probes for specific feline cytokines
Cytokine Primer Sequence (5#–3#) Length Probe Probe sequence (5#–3#) Accession
IL-1 fIL1b.55f AATGACCTGTTCTTTGAGGCTGAT 76 fIL1b.84p CGAAAAGATGAAGGGCAGCCTCCAA M92060
fIL1b.130r CCAGAAAACTGTGGCTCAGGTT








IFN- fIFNa.112f CTTGACGCTCCTGGGACAAA 101 fIFNa.141p TCCCTGCCATCTCCTGTCAGAAGG E04599
fIFNa.212r ACTGGTCTCCACCAGAACACG
TNF- fTNFa.239f CTTCTCGAACTCCGAGTGACAAG 74 fTNFa.266p TAGCCCATGTAGTAGCAAACCCCGAAGC M92061
fTNFa.312r CCACTGGAGTTGCCCTTCA
MIP-1 fMIP1a.17f CTGCCCTCGCCATCCTC 99 fMIP1a.62p TCTTCTCTGCACCATTTGGTGCTGACAC Z14137
fMIP1a.115r ATAGGAGAAGCAGCAGGCAGTT
RANTES fRANTES.157f CTACACCAGCAGCAGTGTTCC 67 fRANTES.180p TGCCCAGCAGTCGTCTTTGTCACCC U22385
fRANTES.223r ACACACCTGGCGCTTCCTC








Clinical and pathological summaries
The ranges in ages of cats in the different treat-
ment groups were 0.5–11 years for the neurologi-
cal FIP group, 0.5–11 years for systemic FIP,
0.5–17 years for neurological non-FIP, and 1–10
years for well-cat controls. Because client-owned
cats were used on the basis of availability, it was
not possible to match controls one to one to cases
on age of other factors; however, there were no
significant differences in mean age among the
four groups (P0.2). The presenting complaints
in the neurological FIP cats included anterior
uveitis (two cats), inappetence (two), lethargy
(three), nystagmus (three), tremors, ataxia and
other cerebellar signs (three), obtundation or
coma (three), paresis or paralysis (four), bizarre
behavior (one), and seizures (one). In cats with
generalized FIP, presenting signs included an-
terior uveitis (two cats), keratic precipitates (two),
weight loss (two), ataxia (one), circling (two),
coma (one), paresis or paralysis (two), and blind-
ness (one). In non-FIP neurological control cats,
presentation included lethargy (one cat), ptyalism
(one), ataxia (one), inappetence (two), blindness
(three), seizures (one), stupor (one), and opistho-
tonos (one). Clinical scores were not statistically
significantly different among the groups (P
0.31).
In the cats for which serum proteins were
evaluated, total proteins ranged from 7.1 to
9.7 mg/dl (mean 8.62±0.87 standard deviation
(s.d.)) in cats with neurological FIP, and from 5.3
to 8.6 mg/dl (mean 7.45±1.46 s.d.) in cats with
generalized FIP. This difference was statistically
significant (P0.06). Globulins ranged from
4–7.3 mg/dl (mean 5.6±1.13 s.d.) in cats with
neurological FIP to 5.3–8.6 (mean 6.9±1.21 s.d.) in
cats with generalized FIP. This difference was not
significant (P0.24).
All cats with FIP and the neurological controls
had abnormal cellular infiltrates in the CNS. One
cat with neurological FIP had only macrophages,
while a cat with generalized FIP had only neu-
trophils in the brain tissue. However, other cats
with neurological FIP had mixtures of lym-
phocytes and plasma cells (one cat), lymphocytes,
macrophages, and plasma cells (two), lym-
phocytes, plasma cells, and neutrophils (one),
macrophages, plasma cells, and neutrophils
(one), eosinophils, macrophages, lymphocytes,
and neutrophils (one), and lymphocytes, macro-
phages, plasma cells, and neutrophils (two). CNS
infiltrates showed less complexity in generalized
FIP with three cases of macrophages with neu-
trophils, two with lymphocytes and plasma
cells, and one with macrophages and neutrophils.
The cats with non-FIP neurological disease had
macrophages (one cat), neutrophils (two), or
lymphocytes, macrophages, and plasma cells
(four).
Pathological lesions in cats with neurological
FIP included choroiditis (five cats), iritis (one),
retinitis (one), uveitis (one), encephalitis (eight),
ependymitis (two), meningitis (nine), and vascu-
litis (seven). In cats with generalized FIP, neuro-
logical lesions included choroiditis (four), retinitis
(one), uveitis (one), ependymitis (two), encepha-
litis (four), meningitis (seven), and vasculitis
(five). The extra-CNS disease included effusive
peritonitis affecting all abdominal organs (one
cat), thoracic effusive FIP (four), pericarditis
(one), nephritis (four), hepatitis (three), and gas-
trointestinal serositis (one). All cats with non-FIP
neuropathies had meningitis, five had encephali-
tis, and four had neoplastic cell infiltration.
Diagnoses included neoplasia and cerebral
cryptococcosis.
Coronavirus characterization: serology and
reverse transcription-polymerase chain
reaction
Anti-coronavirus IgG titers in neurological FIP
ranged from 3200 to 6400, with a geometric mean
of 5381.7. In generalized FIP, the range was
300–6000, with geometric mean of 876.9. This
difference was statistically significant (P0.04).
Unfortunately, because these samples were
evaluated retrospectively, sera for antibody as-
sessment of non-FIP neurological and well-cat
controls were not consistently evaluated. Corona-
virus RT-PCR of brain tissue was negative in con-
trol cats. In cats with FIP, coronavirus RT-PCR
was positive in 13 of the 17 cats. The four RT-PCR-
negative cats had neurological FIP, confirmed by
histopathological evaluation and positive anti-
FIPV N-protein antibody staining (5.2D5, N.
Pedersen, UC, Davis, CA). Relative levels of tran-
scription of coronaviral cDNA ranged from 0 to
2494 times baseline in cats with neurological FIP
(mean 730.41±1004 s.d.). In cats with generalized
FIP, values ranged from 29.94 to 7302 (mean
3551.47±2757 s.d.). These differences were statisti-
cally significant (P0.005). Of the cats tested, the
two cats with no detectable coronaviral cDNA
had the highest antibody titers (6400).
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Cytokine profiles
Cats with generalized FIP had multiple upregu-
lated cytokines with mixed Th1 and Th2 patterns
(Figs 1 and 2). Cats with generalized FIP had
particularly increased transcription of TNF-,
IL-6, and IL-18. In fact, cats with generalized FIP
had the highest cytokine levels of all groups for all
cytokines except IL-10 and IL-12. The cytokines
IL-1 (P0.02), IL-6 (P0.01), IL-18 (P0.05),
TNF- (P0.004), MIP-1 (P0.04), and RANTES
(P0.04) were significantly highest in generalized
FIP than in all other groups, although values for
IL-18 should be interpreted with caution, given
the high within-cat variance for this cytokine. In
addition to generally high mean levels of cyto-
kines in these cats, there was also high variance in
cytokine levels particularly in IL-1, IL-6, TNF-,
IL-18, and IFN-. Cats with neurological FIP had
increased cytokine levels, compared with well-cat
controls, in all cytokines evaluated except IFN-;
IFN- levels in cats with neurological FIP tended
to be lower than even that for well cats, but this
difference was not statistically significant (P
0.3). Levels of IL-6, RANTES, IL-1, IL-18, and
IFN- were particularly high. Variance in cyto-
kine levels was much lower than in generalized
FIP. In non-FIP neurological controls, most cyto-
kines showed no change in mean values com-
pared with well-cat controls, with the exceptions
of IL-4, IL-10, IL-18, and IFN-. Mean IFN- levels
were lower than that for well-cat controls. Vari-
ance was high, particularly with IL-18, IFN-, and
IFN-. When PCA was performed with cats with
neurological FIP, 91.7% of the variance was ac-
counted for in the first two components, with
61.4% in the first component. The loadings for
PC1 were 0.372 for IL-6, 0.329 for MIP-1, and
−0.861 for RANTES, and for PC2 were 0.383 for
IL-1, 0.468 for IL-6, 0.113 for TNF-, 0.652
for MIP-1, and 0.443 for RANTES.
Discussion
Cats with FIP have dramatic cytokine upregu-
lation in the CNS. In neurological FIP, there are
consistent increases in several cytokines, but im-
portantly, far less variability in levels than in gen-
eralized FIP, making neurological FIP a valuable
clinical model for studying the immunopatho-
genesis of FIP. The technique of using archived
brain tissue for RT-PCR with TaqMan PCR
proved sensitive and practical for a variety of
cytokines. Because each assay was calibrated to
an internal RNA GAPDH control for that sample,
loss of signal strength due to formalin fixation,
paraffin-embedding, or archiving duration could
be controlled for. In fact, our laboratory has suc-
cessfully amplified cytokines from cat tissues
as old as 25 years in storage (C. Leutenegger,
unpublished data). Nevertheless, it is important
to include the internal calibrator.
In this study, neurological lesions were histo-
pathologically pleomorphic. The reported pre-
dominating cell types are macrophages and
lymphocytes, and less commonly plasma cells or
neutrophils (Slauson and Finn 1972, Krum et al
1975, Legendre and Whitenack 1975, Kornegay
Fig 1. Comparison of mean (±s.d.) values of IL-1, IL-6,
MIP-1, RANTES, and TNF- in the brain tissue of cats with
primarily neurological FIP, generalized FIP, non-FIP neu-
ropathy, or no disease. Cytokine transcription is expressed as
the n-fold differences to the calibrator.
Fig 2. Comparison of mean (±s.d.) values of IL-4, IL-10,
IL-12, IL-18, IFN-, and IFN- in the brain tissue of cats with
primarily neurological FIP, generalized FIP, non-FIP neu-
ropathy, or no disease. Cytokine transcription is expressed as
the n-fold differences to the calibrator.
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1978, Tamke et al 1988, Summers et al 1995, Foley
et al 1998). In this study, all but one cat with
primary neurological FIP had a lymphocytic com-
ponent to the infiltrate, while lymphocytes were
less typical in the brain lesions of cats with gener-
alized FIP. An earlier report indicated that inflam-
matory cells in FIP lesions include CD4+ T-cells
and IgM- or IgG-producing B-lymphocytes
(Paltrinieri et al 1998). It was interesting to note
that four cats with FIP in the present study
had infiltrates with no detectable macrophages.
Typically, in FIP, the cells expressing antigen are
macrophages, but small lymphocytic cells may
also be positive.
Coronavirus load in the brains of cats with FIP
in this study was comparable with that reported
previously (Foley et al 1998). Previously, 5/16 cats
with neurological FIP were RT-PCR-positive in
cerebrospinal fluid (CSF) and 10/15 were RT-
PCR-positive in brain tissue. In this study, 4/17
cats with FIP had RT-PCR-negative brain tissue.
However, compared with previously used tech-
niques for evaluating coronavirus directly (virus
culture, traditional RT-PCR, and immunohisto-
chemical staining), the TaqMan RT-PCR assay is
extremely sensitive. Nevertheless, even using
TaqMan, there were four histopathologically
confirmed cases of FIP in which coronavirus
RNA could not be detected, most likely due to
localization of virus in areas not sampled for PCR.
Cats with neurological FIP had higher antibody
titers, but lower coronavirus loads than cats with
generalized FIP. Interestingly, of the cats tested,
cats with no detectable coronaviral cDNA had the
highest titers (6400). This could reflect localization
of coronavirus RNA or a primarily immune-
mediated disease initiated by the presence of
coronavirus but operating autonomously with
undetectably low levels of virus. It is unlikely to
have been due to antigen–antibody binding be-
cause the virus would still be available for PCR.
Mouse models of FIP help clarify the significance
of ongoing immune-mediated processes in these
diseases. In MHV-JHM in mice, CD4+ and CD8+
T-cells contribute to viral clearance, but B-cell
products contribute to demyelination; thus SCID
mice (which cannot eliminate virus or make anti-
bodies) have very high viral load but no lesions
in the face of low or undetectable antibodies
(Houtman and Fleming 1996). Antibodies have
been reported to exacerbate clinical FIP (Weiss
and Scott 1981, Vennema et al 1990, Hohdatsu
et al 1991, Corapi et al 1992, Olsen et al 1992).
Thus, for the cats in this study, antibodies may
have been responsible for much of the lesion
development, yet cell-mediated immunity may
have largely contained virus levels in some cats.
Cytokine profiles were analyzed with PCA
because this technique reduced variance to mini-
mum PC and could cope with lack of indepen-
dence among individual cytokines. Only two
components were necessary to capture almost en-
tire observed variance. Unfortunately, because of
the way cases were made available by client re-
quest for euthanasia, it was not possible to match
controls one to one to cases on such possible
sources of variance as age, home quality, concur-
rent disease, and other factors. A few studies have
evaluated changes in cytokine levels directly at-
tributable to age. Using a murine scald injury
model, splenocyte production of both IL-4 and
IL-10 increased with age, while there were no
changes in IFN- or IL-12, and IL-2 production
decreased (Plackett et al 2003); however, after in-
jury, there was a decrease in all of the cytokines
examined, regardless of age. In neonatal foals,
there were no changes during the first 4 weeks of
life in peripheral blood mononuclear cell cytokine
expression of IL-1, IL-2, IL-4, IL-6, IL-8, IL-10,
IL-12p35, IL-12p40, or TNF- (Boyd et al 2003).
The cytokines IFN-, TGF-1, and IL-1 increased
significantly with age. These studies documented
unpredictable changes in cytokine levels across
species and disease models with age. In the
present study, there were no significant differ-
ences among the groups with respect to age. In
fact, the tendency (although not statistically sig-
nificant) was for cats with neurological FIP to be a
little older than cats with systemic FIP, and one
major difference between these groups was that
neurological FIP had lower IFN- levels, a cyto-
kine reported not to decrease with age in Plackett
et al (2003) and to increase with age in Boyd et al
(2003). More importantly, in this study, cytokine
variability in the systemic FIP group was very
high, even though the variance in age was lower
for this group than any other group except the
well-cat control.
In the present study, the PCA loadings impli-
cated IL-6, IL-1, MIP-1, and RANTES as key
factors in the immunopathogenesis. These cyto-
kines share common features in recruiting or
regulating inflammatory cells, and for IL-6,
TNF-, and IL-1, increasing vascular per-
meability. IL-1, which is secreted by many
immune-active cells, also leads to local tissue
destruction, promotes leukocyte adhesion to
the endothelium, and is pyrogenic. IL-6 recruits
and activates T-cells and macrophages, expands
cytotoxic T-lymphocytes, modulates plasma cell
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differentiation, increases vascular permeability,
downregulates acute phase proteins, and contrib-
utes to immune-mediated destruction in the
CNS (Akira et al 1993, Lotz 1995, Tilg et al 1997,
Samoilova et al 1998). Elevations in IL-6 and IL-1
have been reported previously in FIP (Goitsuka
et al 1990, Hasegawa and Hasegawa 1991).
Compared with control cats, brains of cats with
FIP had higher levels of the chemokines, MIP-1
and RANTES, which are chemoattractants for in-
flammatory cells in the brains of cats with FIP.
MIP-1, or macrophage inflammatory protein, is
a chemokine in the conserved C–C family of
chemokines (Davatelis et al 1988). It is secreted by
macrophages, neutrophils, inflammatory fibro-
blasts, astrocytes, and lymphocytes, and chemo-
attractant primarily not only for macrophages
and monocytes but also for T-cells and eosino-
phils. It is pyrogenic and a potentiator of IFN-
production. However, increases in IFN-were not
detected in the present study. RANTES is a T-cell
secreted chemokine that attracts memory T-cells,
dendritic cells, NK cells, eosinophils, basophils,
and macrophages. It promotes tissue infiltration
of these cells, activates adhesion molecules, and
represents one of the more common chemokines
to be upregulated in immune-mediated diseases.
The cytokines IL-1, IL-6, and IL-10 contribute,
to some extent, to B-cell production of antibodies,
which promote the formation of FIP lesions. Pre-
viously reported increases in IL-10 (Dean et al
1997) were not observed in the present study. The
contribution of cell-mediated immunity to FIP is
probably mixed: it may be important for early
containment of FECV and FIPV but is not effective
in late FIP. Cytotoxic T-lymphocytes probably ex-
acerbate lesion formation. In MHV, CD4+ cells
protect mice from encephalomyelitis and are im-
portant in viral clearance but CD4-knockout mice
had less inflammation and demyelination than
intact genotypes (Lane et al 2000). CD4+ cells have
been described as components of FIP granulomas
(Paltrinieri et al 1998). The chronic inflammation
and apparent failure to downregulate inflam-
mation could be due to the absent (IL-12) or weak
(IL-18) responses in cats with FIP. The low-grade
IL-12 and IL-18 responses also help account for
the lack of IFN- upregulation. In experimental
FIP, apoptosis and T-cell depletion have been
noted in the spleen and mesenteric nodes, appar-
ently mediated by cytokines (Haagmans et al
1996). The apoptosis is mediated by cytotoxic
T-lymphocytes and not only serves to reduce
virus load (Shibata et al 1994) but also reduces
inflammation (Schmied et al 1993). CD8+ cells
against coronaviral antigens contributed to
chronic demyelination and exacerbated the
lesions via direct damage in MHV (Perlman et al
1987, Castro et al 1994).
There was no appreciable upregulation of
IFN- or IFN- in any of the treatment groups.
This very important finding may be a key to
understanding why some cats succumb to FIP, if
they are incapable for producing adequate IFN-
or fail to do so for whatever reason. IFN- has
many possible effects, including direct anti-viral
properties, inducing MHC class I expression,
increasing superoxide dismutase, protecting
against oxygen radicals, and increasing cytotoxic-
ity of other cells. IFN- is important for clearance
of MHV (Parra et al 1999), and IFN--knockout
mice are particularly susceptible to granulo-
matous peritonitis if they are naturally infected
with MHV (France et al 1999). Treatment with
anti-IFN- antibody increased mortality in mice
with MHV-JHM, while therapy with IFN- re-
duced mortality and virus load (Smith et al 1991).
IFN--knockout mice had higher viral loads (in
liver) than mice with intact IFN- expression and
more severe lesions, consisting largely of neu-
trophils (Kyuwa et al 1998). Results using IFN- in
FIP in cats have not been highly successful but
there have not been large-scale, well-controlled
clinical trials (eg Mochizuki et al 1994). The three
most likely reasons for poor success might be that
(1) the more widely available product is a human
recombinant IFN-, with possibly different effects
and the one that cats may make antibodies to; (2)
the dysregulated cytokine pattern may vary
enough among cats with FIP that a more targeted,
cat-specific approach may be needed; and (3) it
may be difficult (or impossible) to achieve suf-
ficient levels of the cytokine in the appropriate
tissue. For example, administration of recom-
binant IFN- to mice with MHV-JHM resulted in
reduced virus levels in the liver, but not in the
brain (Smith et al 1991).
In summary, this study compares a panel of
cytokines in the brain tissue of cats with neuro-
logical FIP, cats with generalized FIP, and control
cats, and characterizes major changes in immuno-
logical signals. Because neurological FIP appears
remarkably immunologically homogeneous (in
contrast with systemic FIP), it seems possible that
immune therapy might ultimately be designed
for this syndrome, which could create a balance of
cytokines that might allow a cat to eliminate virus
without developing extensive immune-mediated
lesions. The information presented in this paper
contributes to the understanding of major aspects
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of the immune dysregulation that occurs in FIP.
Future work obviously needs to contrast more
generalized cytokine changes in cats with gener-
alized FIP, and evaluate the ability to change
cytokine levels in the CNS and also evaluate
whether cytokine changes following experimen-
tal manipulation result in a better prognosis for
cats with FIP.
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